The present disclosure relates to novel and advantageous devices and systems for performing vertebral augmentation. Particularly, the present disclosure relates to novel and advantageous balloons and delivery systems for performing vertebral augmentation using a balloon. More particularly, the present disclosure relates to a encapsulation balloon and delivery catheter for inserting the balloon in vivo and filling the balloon with cement.
The background description provided herein is for the purpose of generally presenting the context of the disclosure. Work of the presently named inventors, to the extent it is described in this background section, as well as aspects of the description that may not otherwise qualify as prior art at the time of filing, are neither expressly nor impliedly admitted as prior art against the present disclosure.
Vertebral compression fractures (VCFs) occur when a vertebral body in the spine collapses, which can lead to severe pain, deformity, and loss of height. These fractures commonly occur in the thoracic spine, especially in the lower thoracic spine.
Vertebroplasty is a common treatment for VCFs and was introduced in the United States in the early 1990s. Vertebroplasty is a minimally invasive procedure where high pressure cement is injected into the vertebra. A small needle containing bone cement is injected into the collapsed vertebra. The cement hardens within minutes, strengthening and stabilizing the fractured vertebra. Complications can arise with cement leakage. These may comprise, for example, damage to neural structures, lungs, or leakage into vascular systems.
Since the introduction of vertebroplasty, vertebroplasty procedures expanded as one of the treatment modalities to treat pathologic fractures including vertebral body osteoporotic fractures. The thermal effect and the vertebral body augmentation helped with pain control of these cases. The procedure is done utilizing image guided open or percutaneous techniques where PMMA is mixed with radio-opaque material and then injected into the vertebral body through pedicle portals. It can be done under either local or general anesthesia. The cement is forcibly injected through syringes attached to the portals. This is a high-pressure system and has led in many cases to cement leak from the vertebral body. The reported rate of cement extravasation was 76% when computerized tomography (CT) scans were used. If leakage happens in the neural canal, it can cause neurologic deficits. Other complications reported include pulmonary embolism, infection, and incomplete stabilization. Kyphoplasty was later introduced to minimize risks of cement leak and achieve better sagittal alignment.
Kyphoplasty, a balloon-assisted vertebroplasty alternative for treatment of VCFs, is a modification of the vertebroplasty technique and is a method of vertebral augmentation. Kyphoplasty is a contemporary balloon-assisted vertebroplasty alternative for treatment of vertebral body compression fractures. Kyphoplasty utilizes low pressure cement injection to decrease the problem of cement leakage. Kyphoplasty involves injection of bone cement into a mechanically created bone void within a vertebral body.
More specifically, in kyphoplasty, a balloon is used to create a void in the vertebral space. Kyphoplasty modified the vertebroplasty technique by introducing an inflatable balloon before the cement is injected. The balloon serves to elevate the end plates in an attempt to restore the vertebral body height and sagittal alignment by correcting the kyphosis. The balloon is inserted into the structurally compromised vertebral body, often through a cannula, The balloon is then inflated under high pressure. It is thought that the expanding balloon disrupts the cancellous bone architecture and physiological matrix circumferentially and directs the attendant bony debris and physiological matrix toward the inner cortex of the vertebral body vault, i.e. restores the height of the vertebra. The balloon is then deflated and removed, leaving a bony void or cavity. The remaining void or cavity is filled with an appropriate biomaterial, most often bone cement such as polymethylmethacrylate (PMMA). In most cases, the treatment goals are to reduce or eliminate pain and the risk of progressive fracture of the vertebral body and its likely resulting morbidity, complications, and disability.
An advantage of kyphoplasty is creating a void after balloon removal. This allows cement to be injected in a low pressure void system compared to the high pressure vertebroplasty systems.
A common risk of kyphoplasty is leakage of the PMMA from the cavity, which may cause nerve injury, infection, numbness, or spinal cord compression, or may require corrective procedures resulting from leakage of the cement.
Thus, an encapsulation balloon for use in vertebral augmentation solving the aforementioned problems is desired.
The following presents a simplified summary of one or more embodiments of the present disclosure in order to provide a basic understanding of such embodiments. This summary is not an extensive overview of all contemplated embodiments, and is intended to neither identify key or critical elements of all embodiments, nor delineate the scope of any or all embodiments.
The present disclosure, in one or more embodiments, relates to a system for performing a vertebral augmentation procedure including a delivery device and an encapsulation balloon. The delivery device may include an inflation tube, a push tube provided over a proximal portion of the inflation tube, and a push handle. The inflation tube may have a delivery cannula and an injection port, wherein bone cement can flow through the delivery cannula and out of the injection port. The encapsulation balloon is configured for receiving cement and may be provided over a distal portion of the inflation tube such that the port is provided within the encapsulation balloon.
The present disclosure, in one or more embodiments, additionally relates to a system for performing a vertebral augmentation procedure including a delivery catheter and an encapsulation balloon. The delivery catheter may comprise a central tube, a distal tip assembly, a dispensing tip, and a handle. The central tube includes a proximal end and a distal end and the distal tip assembly is provided at the distal end. The distal tip assembly includes a port wherein bone cement can flow through the central tube, to the distal tip assembly, and out of the port. The dispensing tip is configured for receiving a cement cannula. The handle is removably coupled to the central tube and is configured to receive the dispensing tip. The encapsulation balloon is provided over the distal tip assembly and is configured for receiving bone cement.
The present disclosure, in one or more embodiments, further relates to a system for performing a vertebral augmentation procedure comprising a cement encapsulation system, a catheter delivery system, and an encapsulation balloon. The cement encapsulation system may comprise a cement reservoir having a proximal end and a reservoir distal tip, a stopcock, a syringe for removing air, and a tube. The delivery catheter system may comprise a delivery catheter and a handle. The delivery catheter may comprise a central tube having a distal end and a proximal end, a catheter distal tip assembly. The distal tip assembly may include a port, wherein bone cement can flow through the central tube, to the distal tip assembly, and out of the port. The handle may be removably coupled to the central tube. The cement reservoir may be removably coupled to the delivery catheter. The encapsulation balloon may be provided over the catheter distal tip assembly and may be configured for receiving bone cement
While multiple embodiments are disclosed, still other embodiments of the present disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. As will be realized, the various embodiments of the present disclosure are capable of modifications in various obvious aspects, all without departing from the spirit and scope of the present disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the specification concludes with claims particularly pointing out and distinctly claiming the subject matter that is regarded as forming the various embodiments of the present disclosure, it is believed that the invention will be better understood from the following description taken in conjunction with the accompanying Figures, in which:
The present disclosure relates to a novel and advantageous system and device for treatment of vertebral compression fractures using vertebral augmentation such as vertebroplasty or kyphoplasty. Such system and device may be used to encapsulate cement in a vertebral augmentation procedure. In particular, the present disclosure relates to an encapsulation balloon and delivery catheter for inserting the balloon in vivo and filling the encapsulation balloon with cement.
The system described herein comprises a catheter system for safe delivery of cement into the vertebral body following bone dilation and a method of making such system. The system may use an absorbable encapsulation balloon that utilizes a biodegradable matrix. The balloon may comprise an inflatable portion and an interior shaft. The encapsulation balloon is inserted in similar fashion to a balloon used in standard kyphoplasty but is not retrieved. The encapsulation balloon is maintained in situ and later filled with PMMA or other bone cement material. The balloon may be sealed with a valve that substantially prevents cement extravasation, thus minimizing complications related to cement leak. The encapsulation balloon may be configured to dissolve at a later stage after the PMMA is solid.
In one embodiment, an encapsulation balloon for vertebral augmentation procedures, such as vertebroplasty or kyphoplasty, is provided. The encapsulation balloon may be a biodegradable balloon that leaves hardened cement in place after degradation or may be a permanent balloon that remains in place with the hardened cement. In a biodegradable, or bio-absorbable, encapsulation balloon embodiment, the encapsulation balloon may comprise a biocompatible, biodegradable synthetic material. For example, the balloon may comprise a resomer and dicholoromethane mix. In one embodiment, the balloon comprises a Resomer LC 703 S material. The biodegradable material, or Resomer, may be mixed with a solvent such as Sigma-Aldrich PN 34856-4L Dichloromethane (DCM). The mix ratio may be, for example, 1.6 grams Resomer with 5 cc of Dichlorometane. In other embodiments, the balloon may comprise a PLA, PLGA, pol-caprolactone, polydiaxone, poly(lactide-co-epsilon-caprolactone), combinations thereof, or other biodegradable and/or bioabsorbable material that dissolves after the cement material within the encapsulation balloon solidifies. It is to be understood that any suitable type of biodegradable material may be utilized, including for example, materials having polyglycolic acid (PGA), polylactic acid (PLA), and/or copolymers thereof. In some embodiments, a bio-absorbable encapsulation balloon comprising a bio-absorbable fibrous mesh may be provided.
The balloon may comprise an inflatable portion and an interior shaft within the inflatable portion. In general, the balloon may be formed by forming an inflatable portion, forming an interior shaft, and assembling the balloon by providing the interior shaft within the inflatable portion.
In a non-biodegradable encapsulation balloon embodiment, the cement balloon is not biodegradable and may exist in the body and may comprise, for example, silicone material.
Throughout this document, like element numbers may be used to identify like components in all drawings. In some instances, a component may not be specifically described with reference to a figure and description given elsewhere may apply.
A cavity is created inside the vertebra to be prepared, shown at step 2. This can be done in any suitable manner. For example, this may be done using a balloon tamp (or kyphoplasty balloon). The balloon tamp is inserted through the access catheter and into the vertebral body. The balloon of the balloon tamp is inflated and compacts the soft inner bone, thereby creating a cavity inside the vertebra, and returning the vertebral body to a natural height. The balloon tamp may then be deflated, and removed. In some embodiments, this step may be combined with, and done by, inflation of the encapsulation balloon, described below.
An encapsulation balloon is delivered to the created cavity, shown at step 3. This may be done by coupling the encapsulation balloon to a delivery device such as a delivery catheter. More specifically, the encapsulation balloon may be coupled to an inflation cannula or tube. The encapsulation balloon and inflation cannula are inserted through the access catheter to access the cavity. Insertion may be done using radiographic imaging to position the device.
The encapsulation balloon is inflated to generally fill the cavity, shown at step 4. Inflation is done by inserting bone cement, or other suitable material, into the encapsulation balloon. This may be done using the inflation cannula. When the desired quantity of cement has been injected into the encapsulation balloon, the encapsulation balloon is uncoupled from the delivery device, shown at step 5, and the delivery device is removed, shown at step 6. The access catheter may be removed, shown at step 7.
In some embodiments, a minimal volume, for example 2 ml, of cement may be deployed into the vertebral space prior to filling of the encapsulation balloon, or after filling of the encapsulation balloon but before the encapsulated cement is solidified, to facilitate fixation of the encapsulation balloon, to assist in pain relief, and/or to maintain vertebral stability. The balloon may be designed to allow connection between outside cement and cement inside the balloon. More specifically, the interdigitation of the cement within the trabecula may contribute to immediate pain relief and maintenance of vertebral stability. In one embodiment, the balloon facilitates connection of cement outside of the balloon and cement inside the balloon.
Accordingly, a system for performing vertebral augmentation procedures is provided. In one embodiment, the system includes a delivery device (also referred to as a delivery catheter), a balloon tamp (also referred to as a kyphoplasty balloon), and an encapsulation balloon. The balloon tamp may be used for creating a void in the vertebra and the encapsulation balloon may be used for filling the void created. In some embodiments, the encapsulation balloon may be used for both creating a void in the vertebra and for filling the created void. In such embodiment, no separate balloon tamp is provided.
The system may further comprise an access catheter and a cement cannula. The access catheter may be used to access the vertebral body and may have a tool, such as a stylet, centrally located therein to assist in forming the path to the vertebral body. In some embodiments, a catheter with a balloon tamp may be inserted through the access catheter, the balloon of the balloon tamp inflated to create a void in the vertebral body, the balloon deflated, and the balloon tamp and catheter removed from the access catheter. An encapsulation balloon may be attached to a delivery catheter and the delivery catheter inserted into the access catheter to position the encapsulation balloon in the void in the vertebral body. The cement cannula may engage the delivery catheter to deliver cement to the encapsulation balloon through the delivery catheter. The cement cannula and the delivery catheter may be removed from the access catheter and the access catheter may be removed from the body, all while leaving the encapsulation balloon and cement therein in situ.
While the term “cement” is used herein, it is to be appreciated that any suitable bone replacement material may be used. As is known to those skilled in the art, bone replacement material may be biological, such as demineralized bone matrix, platelet-rich plasma, hydroxyapatite, adjunction of growth factors (like bone morphogenetic protein), or synthetic, such as calcium sulfate, tri-calcium phosphate ceramics, bioactive glasses, or polymer-based substitutes. In general, injectable polymethyl methacrylate (PMMA), composite bone cement, biodegradable bone cement, calcium phosphate cement (CPC), calcium sulfate cements, composite resin materials, and the like may be used. In a specific embodiment, G21 V-Fast/V-Steady™ Bone Cement may be used with the cement encapsulation system disclosed herein. No preference is given to any particular bone replacement material herein and any suitable bone replacement material may be used with the system disclosed herein. In some embodiments a low viscosity cement may be used.
The cement encapsulation system may comprise a cement reservoir (barrel) 212, a hydraulic pump 210, such as a hand-operated hydraulic pump, that may be provided pre-filled with sterile water, and a flexible tube 208 connecting the reservoir to the pump. The reservoir 212 is connected to a catheter delivery system which itself comprises a delivery catheter 200. System accessory instruments may include mixing tools such as a mixer with cement reservoir connection, a VacLok syringe 206, and a 3-way stopcock 204. The VacLok syringe 206 and 3-way stopcock 204 facilitate air removal from the catheter delivery system prior to cement injection. The cement encapsulation system may be used with an introducer cannula having, for example, stainless steel tubing. In some embodiments, the stainless steel tubing may be 5 inches (150 mm) or less, and have an inner diameter of 8 G or more.
The catheter delivery system, described more fully below, may comprise a cannula, a push tube, and a stylet. The catheter delivery system facilitates percutaneous access and delivery of the encapsulation into the vertebral body and cement to the encapsulation balloon. The size of cannula used may be selected based on a patient's anatomy and pathology.
In one embodiment, the balloon tamp for inflation and initial elevation is a a kyphoplasty balloon, and is separate from the encapsulation balloon. In another embodiment, the encapsulation balloon is used to elevate the fracture and no separate balloon tamp or kyphoplasty balloon is provided.
In general, it may be desirable inject 1 ml-6 ml of cement into the encapsulation balloon to approximately fill the created cavity or vertebral space. In one embodiment, the balloon receives approximately 2 ml of cement. The size of the encapsulation balloon and the volume of cement injected into the encapsulation balloon may vary based on the size of the vertebral body being treated. In some embodiments, more than one encapsulation balloon may be used to repair the vertebral body with the plurality of balloons being provided side by side, one in front of the other, and/or stacked. In one embodiment, the encapsulation balloon has an inner lumen diameter of 1.5 mm and an outer diameter of 2 mm.
In some embodiments, the encapsulation balloon may be provided with a radiopaque marker such that it may be viewed under fluoroscopy to ensure proper positioning before being injected with cement. Injection of the encapsulation balloon with cement may be done via a distal port on the catheter or a side port on the catheter. A distal port may have a diameter substantially equal to the diameter of the catheter.
Accordingly, in one embodiment, a delivery catheter including a central tube, also referred to as an inflation tube, having a delivery cannula and a distal end including an injection port is provided. An encapsulation balloon is provided over the distal end of the delivery cannula and in communication with the injection port. The delivery catheter is used to place the encapsulation balloon in a vertebral body and may be inserted through an access catheter. A radiopaque marker may be provided on the encapsulation balloon and/or on a distal portion of the delivery catheter to ensure correct placement of the encapsulation balloon. Cement may be injected through the delivery cannula, out of the port, and into the encapsulation balloon to inflate the encapsulation balloon. The encapsulation balloon may be uncoupled from the delivery catheter and the delivery catheter removed. The encapsulation balloon then remains in the vertebral body and the cement hardens. In some embodiments, the encapsulation balloon biodegrades or bioresorbs after the cement hardens.
In some embodiments, air may be removed from the delivery catheter (also referred to as a delivery cannula) before cement is injected through the delivery catheter into the encapsulation balloon. Referring back to
In some embodiments, a one-way valve may be provided as part of the delivery catheter or as part of the encapsulation balloon to prevent cement from escaping the encapsulation balloon. More specifically, the cement may be injected through the one-way valve to inflate the balloon with the one-way valve preventing cement from escaping the balloon.
a, and 5b illustrate close up views of aspects of a distal portion of the delivery catheter, in accordance with one embodiment.
The encapsulation balloon 21 may be provided over the silicone tube 22 and going around the distal tip of the central tube 20. In some embodiments, the silicone tube 22 may act as a one-way inflation valve for the balloon 21. In other embodiments, the silicone tube 22 may be omitted.
A deployment tube 30, such as a PTFE tube, may be provided over the encapsulation balloon 21. This deployment tube 30 assists to maintain integrity of the encapsulation balloon 21 during deployment through the central tube 20.
A connector piece 14 may be provided along the central tube 20. A dispensing tip 32 may be provided at a proximal end of the central tube 20. The dispensing tip 32 may be configured to receive a cement cannula. A radiopaque marker may be provided over the central tube 20. The radiopaque marker may be, for example, a marker band. In the embodiment shown in
Returning to
As previously discussed, in some embodiments, it may be desirable to remove air from the delivery catheter and the balloon prior to injection of cement into the balloon. This may be done by, for example, by suction of the air, pushing of the air, or evacuation of the air.
Detail will now be given of preparing a cement encapsulation catheter for use and using a cement encapsulation catheter for a vertebral augmentation procedure such as vertebroplasty or kyphoplasty.
The cement reservoir 212 may have an injection port 214, a proximal end 216, a cap (not shown) at the proximal end 216, and a distal end having a distal tip 218 for coupling, directly or indirectly, with the cement encapsulation catheter. Cement is received by the cement reservoir 212 from the cement source 230 such as a cement mixer. In some embodiments, the cement may be mixed in a bone cement mixer and the bone cement mixer 230 coupled to the cement reservoir 212 to fill the cement reservoir with bone cement.
As discussed, the delivery catheter 200 may be provided with a stylet (or stiffening wire) 226 inserted therein. Prior to connection of the 3-way stopcock or valve 204 (shown in
Vacuum is applied inside the cement encapsulation catheter using the VacLok syringe. While maintaining vacuum in the VacLok syringe, the 3-way stopcock is manipulated such that a valve completely blocks the VacLok syringe. This allows cement to flow from the cement reservoir into the cement encapsulation catheter. The pump handle can be rotated to introduce the cement into the cement encapsulation catheter. Fluoroscopic imaging may be used throughout the procedure to verify and monitor cement flow as appropriate. At any point during introduction of the cement, cement flow may be stopped by rotating the pump handle counter-clockwise until force-free handle rotation is achieved. When an appropriate amount of cement has been introduced, cement introduction may be stopped (such as by rotating the pump handle counter-clockwise), and the cement reservoir may be removed.
Once filled with cement, the encapsulation balloon is removed from the delivery system and the delivery system is removed. Removing the encapsulation balloon from the delivery system may comprise pushing the encapsulation balloon from the cement encapsulation catheter. This may be done by using a push tube such as described in
In some embodiments, two cement encapsulation balloons may be inserted into a vertebral body.
As used herein, the terms “substantially” or “generally” refer to the complete or nearly complete extent or degree of an action, characteristic, property, state, structure, item, or result. For example, an object that is “substantially” or “generally” enclosed would mean that the object is either completely enclosed or nearly completely enclosed. The exact allowable degree of deviation from absolute completeness may in some cases depend on the specific context. However, generally speaking, the nearness of completion will be so as to have generally the same overall result as if absolute and total completion were obtained. The use of “substantially” or “generally” is equally applicable when used in a negative connotation to refer to the complete or near complete lack of an action, characteristic, property, state, structure, item, or result. For example, an element, combination, embodiment, or composition that is “substantially free of” or “generally free of” an element may still actually contain such element as long as there is generally no significant effect thereof.
To aid the Patent Office and any readers of any patent issued on this application in interpreting the claims appended hereto, applicants wish to note that they do not intend any of the appended claims or claim elements to invoke 35 U.S.C. § 112(f) unless the words “means for” or “step for” are explicitly used in the particular claim.
Additionally, as used herein, the phrase “at least one of [X] and [Y],” where X and Y are different components that may be included in an embodiment of the present disclosure, means that the embodiment could include component X without component Y, the embodiment could include the component Y without component X, or the embodiment could include both components X and Y. Similarly, when used with respect to three or more components, such as “at least one of [X], [Y], and [Z],” the phrase means that the embodiment could include any one of the three or more components, any combination or sub-combination of any of the components, or all of the components.
In the foregoing description various embodiments of the present disclosure have been presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise form disclosed. Obvious modifications or variations are possible in light of the above teachings. The various embodiments were chosen and described to provide the best illustration of the principals of the disclosure and their practical application, and to enable one of ordinary skill in the art to utilize the various embodiments with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the present disclosure as determined by the appended claims when interpreted in accordance with the breadth they are fairly, legally, and equitably entitled.
The present application claims the benefit of to U.S. Provisional Application No. 63/272,523, filed on 27 Oct. 2021, the entire contents of which are incorporated herein by reference. A claim of priority to all, to the extent appropriate, is made.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/048107 | 10/27/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63272523 | Oct 2021 | US |